Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00161980 | Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites | PHASE3 | COMPLETED | - | — | — | Jun 1, 2001 | Dec 1, 2002 | Oct 23, 2006 | 8 | Austria, France +2 |
| Name | Type | Description |
|---|---|---|
| Fibrin Sealant VH S/D | DRUG | - |
| Surgical intervention alone without Fibrin Sealant VH S/D application | PROCEDURE | - |
Inclusion Criteria: * Written informed consent has been obtained from the subject prior to FS VH S/D administration * Female subjects \>= 19 years of age * Subjects with breast cancer scheduled to undergo lumpectomy of the breast and level I and II axillary lymphadenectomy with two separate incisio...